Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
Also known as: Recurrent Non-Squamous Non-Small Cell Lung Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
DB08911 | Trametinib | 1 | Active Not Recruiting | 1 |
DB00062 | Albumin human | 2 | Active Not Recruiting | 1 |
DB11945 | Avelumab | 2 | Active Not Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Completed | 1 |
DB01248 | Docetaxel | 2 | Active Not Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Completed | 1 |
DB06599 | Lexatumumab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Completed | 1 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB05578 | Ramucirumab | 2 | Active Not Recruiting | 1 |
DB12332 | Rucaparib | 2 | Active Not Recruiting | 1 |
DB15569 | Sotorasib | 2 | Recruiting | 1 |
DB11760 | Talazoparib | 2 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 3 | Recruiting | 1 |
DB09330 | Osimertinib | 3 | Recruiting | 1 |